RxAnte last raised $10.9M in its Debt (Oct 2020).
- ·Watch RxAnte: the Monday email on marks, rounds and moves
RxAnte funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2020 | Debt | $10.9M | ▮ | ▮ |
Membership and data by Private Market View
RxAnte valuation
RxAnte's last known valuation is $28.9 million, from Nov 2020. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has RxAnte raised?
RxAnte has raised $49.8 million in total; 1 of its rounds is on record. The largest on record was a $10.9 million debt round in Oct 2020.
RxAnte has filed 2 Form Ds with the SEC since 2020, most recently in May 2022 ($10.9 million sold to 7 investors).
How RxAnte's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For RxAnte, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about RxAnte
- What is RxAnte worth?
- RxAnte's last known valuation is $28.9M.
- How much has RxAnte raised?
- RxAnte has raised $49.8M in total funding across 1 recorded rounds.
- When did RxAnte last raise?
- RxAnte last raised in Oct 2020 (Debt), raising $10.9M.